Hemimegalencephaly

Status: draft · Last updated 2026-11-17 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • HME = mosaic gain of function in PI3K–AKT–mTOR (PIK3CA, AKT3, MTOR) in the brain. Blood testing is usually negative .
  • Epilepsy: neonatal-onset (median day 3 in one series) and drug-resistant .
  • Hemispheric surgery:
    • about half seizure-free long term;
    • about 30% need a shunt and about 29% need revision .
  • Better outcomes: younger onset, no epilepsia partialis continua, no contralateral EEG seizures .
  • Infant surgery is feasible but bloody: every infant was transfused, a third with more than one blood volume, with 13% bleeding and 7% cardiac arrest .
  • Staged embolization is an emerging option under 12 weeks of age .

Hemimegalencephaly (HME) is overgrowth of one cerebral hemisphere . It is a malformation of cortical development that presents with early, drug-resistant epilepsy, often from the first days of life .

Hemispheric surgery is the mainstay of treatment. It is among the most demanding operations in pediatric epilepsy surgery, with substantial perioperative risk in infants .

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:hemimegalencephaly:627eb7fab5620eca© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Axial T2-style image with an enlarged left hemisphere, thick dysplastic cortex, blurred grey-white junction, enlarged ventricle with a straightened frontal horn and midline shift; a somatic mosaic PI3K-AKT-mTOR pathway; and functional hemispherotomy, anatomic hemispherectomy and staged embolization(A) AXIAL MRI (T2-STYLE, RADIOLOGICAL: LEFT ON VIEWER'S RIGHT)straightened frontal horn,pointing up and forwardenlarged lateral ventriclethick dysplastic cortex,blurred grey-white junctionenlarged left hemispheremidline shifted to thenormal sidenormal right hemisphere(B) SOMATIC MOSAIC mTOR PATHWAYpatchy mosaic cell populationPI3KAKTmTORsomatic mosaic: PIK3CA, AKT3, MTOR(C) SURGICAL OPTIONSFunctional hemispherotomydisconnection, most tissue leftAnatomic hemispherectomyhemisphere removedStaged transarterialembolization (young infants)
Hemimegalencephaly. (a) Axial MRI-style view: an enlarged left hemisphere with thick, dysplastic cortex, blurred grey–white junction, an enlarged and straightened lateral ventricle (frontal horn pointing anteriorly and upward), and midline shift; normal right hemisphere. (b) PI3K–AKT–mTOR pathway with somatic gain-of-function variants (PIK3CA, AKT3, MTOR) in a mosaic patch of brain. (c) Surgical options: functional hemispherectomy or hemispherotomy disconnecting the hemisphere, versus anatomic hemispherectomy; staged transarterial embolization in very young infants. Not to scale.

Cause

Presentation

Surgery

Choosing the operation

Infants under 12 months

Staged transarterial embolization (an alternative in the youngest infants)

Related topics

References

  1. Lee JH, Huynh M, Silhavy JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012;44(8):941–945. doi:10.1038/ng.2329. PMID 22729223. verified
  2. Pielas M, Kotulska K, Roszkowski M, et al. Hemispheric surgery for hemimegalencephaly and hemispheric cortical dysplasia in infants below 12 months of age: a single-center experience. Epilepsia 2026;67(8):3996–4007. doi:10.1002/epi.70294. PMID 42132620. verified
  3. Goel K, Phillips HW, Chen JS, et al. Hemispheric epilepsy surgery for hemimegalencephaly: the UCLA experience. Epilepsia 2024;65(1):57–72. doi:10.1111/epi.17807. PMID 37873610. verified
  4. Israel S, Wolff N, Ruffini L, et al. Transarterial embolization versus hemispherectomy in infants with hemimegalencephaly and drug-resistant epilepsy. Pediatr Res 2026;99(4):1523–1531. doi:10.1038/s41390-025-04405-2. PMID 41028505. verified

Verification (2026-11-17):

Caveats: